Concord Drugs Ltd (CONCORD) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 45.08% of Concord Drugs Ltd, FIIs -, DIIs -, government - and the public 54.92%, across 4,435 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 54.39% | 54.39% | 54.39% | 54.39% | 54.39% | 54.39% | 54.39% | 45.08% |
| Public | 45.61% | 45.61% | 45.61% | 45.61% | 45.61% | 45.61% | 45.61% | 54.92% |
| No. of Shareholders | 5,073 | 5,073 | 5,252 | 5,189 | 4,718 | 4,597 | 4,464 | 4,435 |